Henderson Group »

Relmada Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $77M 11M 6.95

More positions owned by Henderson Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Astrazeneca Ord (AZN)
Mastercard Incorporated Cl A (MA)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)
Argenx Se Sponsored Adr (ARGX)
Kla Corp Com New (KLAC)

View all positions for Henderson Group

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
OrbiMed Advisors
Adage Capital Partners GP
Millennium Management
Marshall Wace
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management

View all funds holding Relmada Therapeutics